2011.03.10 Weekly Broadcast Email
The following update was made to the CCCWFU CCOP Research Base website for the week of March 7, 2011.
98110:(A Randomized Phase II Dose Finding Study of ArginMax with or without Phosphodiesterase-5 Inhibitors for Its Effect on Erectile Function and Quality of Life in Survivors of Prostate Cancer Previously Treated with Radiotherapy)
Amendment 2 has been added to the website. This amendment includes protocol, consent and appendix changes.